Top Markets
Coin of the day
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Pozycja w akcjach #827
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Cena akcji
$71.46
Kapitalizacja rynkowa
$29.96B
Zmiana (1 dzień)
-0.04%
Zmiana (1 rok)
-51.01%
Kraj
US
Handel Zoetis Inc. (ZTS)

Kategoria

Marża operacyjna dla Zoetis Inc. (ZTS)
Marża operacyjna na dzień September 2026 TTM: 37.00%
Według najnowszych raportów finansowych i ceny akcji Zoetis Inc., bieżąca marża operacyjna (TTM) wynosi 37.00%. Na koniec 2023 wynosiła 35.92%.
Historia marży operacyjnej dla Zoetis Inc. od 2009 do 2026
Marża operacyjna na koniec każdego roku
Rok Marża operacyjna Zmień
2026 (TTM) 37.00% 0.95%
2024 36.65% 2.03%
2023 35.92% -0.88%
2022 36.24% 0.53%
2021 36.05% 6.06%
2020 33.99% 5.43%
2019 32.24% -0.15%
2018 32.29% -0.77%
2017 32.54% 13.30%
2016 28.72% 26.46%
2015 22.71% 12.04%
2014 20.27% 12.61%
2013 18.00% -8.63%
2012 19.70% 21.91%
2011 16.16% 87.25%
2010 8.63% -15.23%
2009 10.18% 0.00%
Marża operacyjna dla podobnych firm lub konkurentów
Firma Marża operacyjna Różnica w marży operacyjnej Kraj
43.92% -98.81%
US
26.81% -99.28%
US
29.32% -99.21%
US
26.59% -99.28%
CH
16.65% -99.55%
US
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.